GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Accounts Payable

Embecta (FRA:JX7) Accounts Payable : €48 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Accounts Payable?

Embecta's Accounts Payable for the quarter that ended in Mar. 2024 was €48 Mil.

Embecta's quarterly Accounts Payable declined from Sep. 2023 (€50 Mil) to Dec. 2023 (€39 Mil) but then increased from Dec. 2023 (€39 Mil) to Mar. 2024 (€48 Mil).

Embecta's annual Accounts Payable declined from Sep. 2021 (€46 Mil) to Sep. 2022 (€42 Mil) but then increased from Sep. 2022 (€42 Mil) to Sep. 2023 (€50 Mil).


Embecta Accounts Payable Historical Data

The historical data trend for Embecta's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Accounts Payable Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
Accounts Payable
- 42.45 46.07 41.81 50.13

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.04 51.78 50.13 38.61 48.39

Embecta Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Embecta Accounts Payable Related Terms

Thank you for viewing the detailed overview of Embecta's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta (FRA:JX7) Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines